TRIV

TriVascular Technologies, Inc.CIK 1432732 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for TRIV PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for TRIV

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Jayaraman Vivek K	VP Global Sales and Marketing	12	$0	$0	2016-02-03
O'Quinn Shari L	VP Clinical/Regulatory Affairs	11	$0	$0	2016-02-03
Chobotov Michael V.	Chief Technology Officer	12	$0	$0	2016-02-03
Elting Kimberley A.	VP, Gen. Counsel and Secretary	12	$0	$0	2016-02-03
Moore Daniel Jeffrey	Director	5	$0	$0	2016-02-03
NEA 12 GP, LLC	10% Owner	1	$0	$0	2016-02-03
Kramer Michael R	Chief Financial Officer	12	$0	$0	2016-02-03
Scopa James Paul	Director	15	$0	$0	2016-02-03
DELPHI BIOINVESTMENTS VII LP	10% Owner	1	$0	$0	2016-02-03
Thomas Robert	Director	18	$0	$0	2016-02-03
ROEDER DOUGLAS A	Director, 10% Owner	17	$10.00M	$0	2016-02-03
Chavez Christopher G.	President, CEO and Chairman	13	$0	$0	2016-02-03
Nunn Jason Raleigh	Director	1	$0	$0	2015-05-22
DRANT RYAN D	Director, 10% Owner	15	$7.00M	$0	2015-05-22
Molinari Louis J.	VP Manufacturing Operations	3	$0	$0	2015-03-02
Whirley Robert G	VP Research and Development	3	$0	$0	2015-03-02
MPM BioVentures IV QP LP	10% Owner	12	$0	$0	2014-04-22
Flynn James E	10% Owner	16	$12.79M	$0	2014-04-22
BOCHNOWSKI JAMES J	10% Owner	14	$10.00M	$0	2014-04-22
KERINS PATRICK J	10% Owner	13	$7.00M	$0	2014-04-22

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
Kramer Michael R	Chief Financial Officer	M Exercise deriv	2016-02-03	2016-02-04	16,032	—	$0	0	SEC↗
Kramer Michael R	Chief Financial Officer	M Exercise deriv	2016-02-03	2016-02-04	15,000	—	$0	0	SEC↗
Chavez Christopher G.	President, CEO and Chairman	M Exercise deriv	2016-02-03	2016-02-04	29,720	—	$0	0	SEC↗
Chavez Christopher G.	President, CEO and Chairman	M Exercise deriv	2016-02-03	2016-02-04	83,603	—	$0	0	SEC↗
Chobotov Michael V.	Chief Technology Officer	M Exercise deriv	2016-02-03	2016-02-04	12,400	—	$0	0	SEC↗
Chobotov Michael V.	Chief Technology Officer	M Exercise deriv	2016-02-03	2016-02-04	22,137	—	$0	0	SEC↗
Elting Kimberley A.	VP, Gen. Counsel and Secreta	M Exercise deriv	2016-02-03	2016-02-04	61,621	—	$0	0	SEC↗
Elting Kimberley A.	VP, Gen. Counsel and Secreta	M Exercise deriv	2016-02-03	2016-02-04	15,000	—	$0	0	SEC↗
Jayaraman Vivek K	VP Global Sales and Marketin	M Exercise deriv	2016-02-03	2016-02-04	12,400	—	$0	0	SEC↗
Jayaraman Vivek K	VP Global Sales and Marketin	M Exercise deriv	2016-02-03	2016-02-04	47,778	—	$0	0	SEC↗
O'Quinn Shari L	VP Clinical/Regulatory Affai	M Exercise deriv	2016-02-03	2016-02-04	41,838	—	$0	0	SEC↗
O'Quinn Shari L	VP Clinical/Regulatory Affai	M Exercise deriv	2016-02-03	2016-02-04	9,400	—	$0	0	SEC↗
Moore Daniel Jeffrey	Director	M Exercise deriv	2016-02-03	2016-02-04	15,661	—	$0	0	SEC↗
Thomas Robert	Director	M Exercise deriv	2016-02-03	2016-02-04	16,523	—	$0	0	SEC↗
Scopa James Paul	Director	D To issuer	2016-02-03	2016-02-04	1,776,692	—	$0	0	SEC↗
Kramer Michael R	Chief Financial Officer	M Exercise	2016-02-03	2016-02-04	16,032	$2.43	$39.0K	108,341	SEC↗
Kramer Michael R	Chief Financial Officer	F Tax w/h	2016-02-03	2016-02-04	6,561	$5.62	$36.9K	100,748	SEC↗
Kramer Michael R	Chief Financial Officer	M Exercise	2016-02-03	2016-02-04	15,000	—	$0	107,309	SEC↗
Kramer Michael R	Chief Financial Officer	F Tax w/h	2016-02-03	2016-02-04	7,238	$5.62	$40.7K	101,103	SEC↗
Kramer Michael R	Chief Financial Officer	D To issuer	2016-02-03	2016-02-04	8,794	—	$0	92,309	SEC↗
Kramer Michael R	Chief Financial Officer	D To issuer	2016-02-03	2016-02-04	92,309	—	$0	0	SEC↗
Kramer Michael R	Chief Financial Officer	D To issuer	2016-02-03	2016-02-04	8,439	—	$0	92,309	SEC↗
Chavez Christopher G.	President, CEO and Chairman	D To issuer	2016-02-03	2016-02-04	60,168	—	$0	659,952	SEC↗
Chavez Christopher G.	President, CEO and Chairman	D To issuer	2016-02-03	2016-02-04	659,952	—	$0	0	SEC↗
Chavez Christopher G.	President, CEO and Chairman	M Exercise	2016-02-03	2016-02-04	29,720	$3.25	$96.6K	689,672	SEC↗
Chavez Christopher G.	President, CEO and Chairman	F Tax w/h	2016-02-03	2016-02-04	21,279	$5.62	$119.6K	668,393	SEC↗
Chavez Christopher G.	President, CEO and Chairman	M Exercise	2016-02-03	2016-02-04	83,603	—	$0	743,555	SEC↗
Chavez Christopher G.	President, CEO and Chairman	F Tax w/h	2016-02-03	2016-02-04	23,435	$5.62	$131.7K	720,120	SEC↗
Chavez Christopher G.	President, CEO and Chairman	D To issuer	2016-02-03	2016-02-04	8,441	—	$0	659,952	SEC↗
Chobotov Michael V.	Chief Technology Officer	M Exercise	2016-02-03	2016-02-04	22,137	$2.43	$53.8K	196,224	SEC↗
Chobotov Michael V.	Chief Technology Officer	D To issuer	2016-02-03	2016-02-04	7,064	—	$0	174,087	SEC↗
Chobotov Michael V.	Chief Technology Officer	F Tax w/h	2016-02-03	2016-02-04	15,073	$5.62	$84.7K	181,151	SEC↗
Chobotov Michael V.	Chief Technology Officer	D To issuer	2016-02-03	2016-02-04	174,087	—	$0	0	SEC↗
Chobotov Michael V.	Chief Technology Officer	D To issuer	2016-02-03	2016-02-04	6,971	—	$0	174,087	SEC↗
Chobotov Michael V.	Chief Technology Officer	F Tax w/h	2016-02-03	2016-02-04	5,429	$5.62	$30.5K	181,058	SEC↗
Chobotov Michael V.	Chief Technology Officer	M Exercise	2016-02-03	2016-02-04	12,400	—	$0	186,487	SEC↗
Elting Kimberley A.	VP, Gen. Counsel and Secreta	M Exercise	2016-02-03	2016-02-04	61,621	$3.25	$200.3K	65,740	SEC↗
Elting Kimberley A.	VP, Gen. Counsel and Secreta	M Exercise	2016-02-03	2016-02-04	15,000	—	$0	19,119	SEC↗
Elting Kimberley A.	VP, Gen. Counsel and Secreta	F Tax w/h	2016-02-03	2016-02-04	4,898	$5.62	$27.5K	14,221	SEC↗
Elting Kimberley A.	VP, Gen. Counsel and Secreta	D To issuer	2016-02-03	2016-02-04	10,102	—	$0	4,119	SEC↗
Elting Kimberley A.	VP, Gen. Counsel and Secreta	F Tax w/h	2016-02-03	2016-02-04	35,635	$5.62	$200.3K	30,105	SEC↗
Elting Kimberley A.	VP, Gen. Counsel and Secreta	D To issuer	2016-02-03	2016-02-04	25,986	—	$0	4,119	SEC↗
Elting Kimberley A.	VP, Gen. Counsel and Secreta	D To issuer	2016-02-03	2016-02-04	4,119	—	$0	0	SEC↗
NEA 12 GP, LLC	10% Owner	D To issuer	2016-02-03	2016-02-04	3,943,269	—	$0	0	SEC↗
Jayaraman Vivek K	VP Global Sales and Marketin	D To issuer	2016-02-03	2016-02-04	27,081	—	$0	6,270	SEC↗
Jayaraman Vivek K	VP Global Sales and Marketin	F Tax w/h	2016-02-03	2016-02-04	20,697	$5.62	$116.3K	33,351	SEC↗
Jayaraman Vivek K	VP Global Sales and Marketin	D To issuer	2016-02-03	2016-02-04	6,270	—	$0	0	SEC↗
Jayaraman Vivek K	VP Global Sales and Marketin	M Exercise	2016-02-03	2016-02-04	47,778	$2.43	$116.1K	54,048	SEC↗
Jayaraman Vivek K	VP Global Sales and Marketin	M Exercise	2016-02-03	2016-02-04	12,400	—	$0	18,670	SEC↗
Jayaraman Vivek K	VP Global Sales and Marketin	D To issuer	2016-02-03	2016-02-04	6,971	—	$0	6,270	SEC↗
Jayaraman Vivek K	VP Global Sales and Marketin	F Tax w/h	2016-02-03	2016-02-04	5,429	$5.62	$30.5K	13,241	SEC↗
O'Quinn Shari L	VP Clinical/Regulatory Affai	M Exercise	2016-02-03	2016-02-04	41,838	$2.43	$101.7K	41,838	SEC↗
O'Quinn Shari L	VP Clinical/Regulatory Affai	F Tax w/h	2016-02-03	2016-02-04	3,549	$5.62	$19.9K	5,851	SEC↗
O'Quinn Shari L	VP Clinical/Regulatory Affai	M Exercise	2016-02-03	2016-02-04	9,400	—	$0	9,400	SEC↗
O'Quinn Shari L	VP Clinical/Regulatory Affai	F Tax w/h	2016-02-03	2016-02-04	18,092	$5.62	$101.7K	23,746	SEC↗
O'Quinn Shari L	VP Clinical/Regulatory Affai	D To issuer	2016-02-03	2016-02-04	23,746	—	$0	0	SEC↗
O'Quinn Shari L	VP Clinical/Regulatory Affai	D To issuer	2016-02-03	2016-02-04	5,851	—	$0	0	SEC↗
Moore Daniel Jeffrey	Director	M Exercise	2016-02-03	2016-02-04	15,661	$2.43	$38.1K	15,661	SEC↗
Moore Daniel Jeffrey	Director	F Tax w/h	2016-02-03	2016-02-04	6,772	$5.62	$38.1K	8,889	SEC↗
Moore Daniel Jeffrey	Director	D To issuer	2016-02-03	2016-02-04	8,889	—	$0	0	SEC↗
Thomas Robert	Director	M Exercise	2016-02-03	2016-02-04	16,523	$2.43	$40.2K	106,639	SEC↗
Thomas Robert	Director	F Tax w/h	2016-02-03	2016-02-04	7,145	$5.62	$40.2K	99,494	SEC↗
Thomas Robert	Director	D To issuer	2016-02-03	2016-02-04	9,378	—	$0	90,116	SEC↗
Thomas Robert	Director	D To issuer	2016-02-03	2016-02-04	90,116	—	$0	0	SEC↗
DELPHI BIOINVESTMENTS VII LP	10% Owner	U Tender	2016-02-03	2016-02-05	3,535,910	—	$0	0	SEC↗
ROEDER DOUGLAS A	Director, 10% Owner	U Tender	2016-02-03	2016-02-05	3,535,910	—	$0	0	SEC↗
ROEDER DOUGLAS A	Director, 10% Owner	D To issuer	2016-02-03	2016-02-05	149	—	$0	0	SEC↗
ROEDER DOUGLAS A	Director, 10% Owner	A Award deriv	2015-05-22	2015-05-27	10,000	—	$0	10,000	SEC↗
Thomas Robert	Director	A Award deriv	2015-05-22	2015-05-27	10,000	—	$0	10,000	SEC↗
Scopa James Paul	Director	A Award deriv	2015-05-22	2015-05-27	10,000	—	$0	10,000	SEC↗
Moore Daniel Jeffrey	Director	A Award deriv	2015-05-22	2015-05-27	10,000	—	$0	10,000	SEC↗
DRANT RYAN D	Director, 10% Owner	A Award deriv	2015-05-22	2015-05-27	10,000	—	$0	10,000	SEC↗
Nunn Jason Raleigh	Director	A Award deriv	2015-05-22	2015-05-27	10,000	—	$0	10,000	SEC↗
Jayaraman Vivek K	VP Global Sales and Marketin	A Award deriv	2015-03-02	2015-03-04	12,400	—	$0	12,400	SEC↗
Jayaraman Vivek K	VP Global Sales and Marketin	A Award deriv	2015-03-02	2015-03-04	23,400	—	$0	23,400	SEC↗
Chobotov Michael V.	Chief Technology Officer	A Award deriv	2015-03-02	2015-03-04	23,400	—	$0	23,400	SEC↗
Chobotov Michael V.	Chief Technology Officer	A Award deriv	2015-03-02	2015-03-04	12,400	—	$0	12,400	SEC↗
Whirley Robert G	VP Research and Development	A Award deriv	2015-03-02	2015-03-04	17,700	—	$0	17,700	SEC↗
Whirley Robert G	VP Research and Development	A Award deriv	2015-03-02	2015-03-04	9,400	—	$0	9,400	SEC↗
Molinari Louis J.	VP Manufacturing Operations	A Award deriv	2015-03-02	2015-03-04	9,400	—	$0	9,400	SEC↗
Molinari Louis J.	VP Manufacturing Operations	A Award deriv	2015-03-02	2015-03-04	17,700	—	$0	17,700	SEC↗
O'Quinn Shari L	VP Clinical/Regulatory Affai	A Award deriv	2015-03-02	2015-03-04	9,400	—	$0	9,400	SEC↗
O'Quinn Shari L	VP Clinical/Regulatory Affai	A Award deriv	2015-03-02	2015-03-04	17,700	—	$0	17,700	SEC↗
Kramer Michael R	Chief Financial Officer	A Award deriv	2015-03-02	2015-03-04	15,000	—	$0	15,000	SEC↗
Kramer Michael R	Chief Financial Officer	A Award deriv	2015-03-02	2015-03-04	28,400	—	$0	28,400	SEC↗
Chavez Christopher G.	President, CEO and Chairman	A Award deriv	2015-03-02	2015-03-04	45,100	—	$0	45,100	SEC↗
Chavez Christopher G.	President, CEO and Chairman	A Award deriv	2015-03-02	2015-03-04	85,100	—	$0	85,100	SEC↗
Chavez Christopher G.	President, CEO and Chairman	A Award deriv	2015-03-02	2015-03-04	38,503	—	$0	38,503	SEC↗
Elting Kimberley A.	VP, Gen. Counsel and Secreta	A Award deriv	2015-03-02	2015-03-04	15,000	—	$0	15,000	SEC↗
Elting Kimberley A.	VP, Gen. Counsel and Secreta	A Award deriv	2015-03-02	2015-03-04	28,400	—	$0	28,400	SEC↗
Flynn James E	10% Owner	C Conversion deriv	2014-04-22	2014-04-22	71,333	—	$0	0	SEC↗
Flynn James E	10% Owner	C Conversion deriv	2014-04-22	2014-04-22	86,834	—	$0	0	SEC↗
Flynn James E	10% Owner	C Conversion deriv	2014-04-22	2014-04-22	221,118	—	$0	0	SEC↗
Flynn James E	10% Owner	C Conversion deriv	2014-04-22	2014-04-22	253,384	—	$0	0	SEC↗
Scopa James Paul	Director	C Conversion deriv	2014-04-22	2014-04-23	1,516,122	—	$0	0	SEC↗
Scopa James Paul	Director	C Conversion deriv	2014-04-22	2014-04-23	20,757,635	—	$0	0	SEC↗
Scopa James Paul	Director	C Conversion deriv	2014-04-22	2014-04-23	6,000,000	—	$0	0	SEC↗
Scopa James Paul	Director	C Conversion deriv	2014-04-22	2014-04-23	2,947,605	—	$0	0	SEC↗
Scopa James Paul	Director	C Conversion deriv	2014-04-22	2014-04-23	15,400,411	—	$0	0	SEC↗
Scopa James Paul	Director	C Conversion deriv	2014-04-22	2014-04-23	10,266,940	—	$0	0	SEC↗
Scopa James Paul	Director	C Conversion deriv	2014-04-22	2014-04-23	37,369	—	$0	37,369	SEC↗
MPM BioVentures IV QP LP	10% Owner	C Conversion deriv	2014-04-22	2014-04-23	1,516,122	—	$0	0	SEC↗
MPM BioVentures IV QP LP	10% Owner	C Conversion deriv	2014-04-22	2014-04-23	15,400,411	—	$0	0	SEC↗
MPM BioVentures IV QP LP	10% Owner	C Conversion deriv	2014-04-22	2014-04-23	37,369	—	$0	37,369	SEC↗
MPM BioVentures IV QP LP	10% Owner	C Conversion deriv	2014-04-22	2014-04-23	20,757,635	—	$0	0	SEC↗
MPM BioVentures IV QP LP	10% Owner	C Conversion deriv	2014-04-22	2014-04-23	6,000,000	—	$0	0	SEC↗
MPM BioVentures IV QP LP	10% Owner	C Conversion deriv	2014-04-22	2014-04-23	10,266,940	—	$0	0	SEC↗
MPM BioVentures IV QP LP	10% Owner	C Conversion deriv	2014-04-22	2014-04-23	2,947,605	—	$0	0	SEC↗
KERINS PATRICK J	10% Owner	C Conversion deriv	2014-04-22	2014-04-24	797,208	—	$0	0	SEC↗
KERINS PATRICK J	10% Owner	C Conversion deriv	2014-04-22	2014-04-24	531,758	—	$0	0	SEC↗
KERINS PATRICK J	10% Owner	C Conversion deriv	2014-04-22	2014-04-24	1,236,487	—	$0	0	SEC↗
KERINS PATRICK J	10% Owner	C Conversion deriv	2014-04-22	2014-04-24	411,234	—	$0	0	SEC↗
KERINS PATRICK J	10% Owner	C Conversion deriv	2014-04-22	2014-04-24	55,831	$15.81	$882.7K	0	SEC↗
KERINS PATRICK J	10% Owner	C Conversion deriv	2014-04-22	2014-04-24	383,249	—	$0	0	SEC↗
KERINS PATRICK J	10% Owner	C Conversion deriv	2014-04-22	2014-04-24	55,831	—	$0	55,831	SEC↗
DRANT RYAN D	Director, 10% Owner	C Conversion deriv	2014-04-22	2014-04-24	411,234	—	$0	0	SEC↗
DRANT RYAN D	Director, 10% Owner	C Conversion deriv	2014-04-22	2014-04-24	1,236,487	—	$0	0	SEC↗
DRANT RYAN D	Director, 10% Owner	C Conversion deriv	2014-04-22	2014-04-24	531,758	—	$0	0	SEC↗
DRANT RYAN D	Director, 10% Owner	C Conversion deriv	2014-04-22	2014-04-24	383,249	—	$0	0	SEC↗
DRANT RYAN D	Director, 10% Owner	C Conversion deriv	2014-04-22	2014-04-24	797,208	—	$0	0	SEC↗
DRANT RYAN D	Director, 10% Owner	C Conversion deriv	2014-04-22	2014-04-24	55,831	—	$0	55,831	SEC↗
DRANT RYAN D	Director, 10% Owner	C Conversion deriv	2014-04-22	2014-04-24	55,831	$15.81	$882.7K	0	SEC↗
BOCHNOWSKI JAMES J	10% Owner	C Conversion deriv	2014-04-22	2014-04-24	970,167	—	$0	0	SEC↗
BOCHNOWSKI JAMES J	10% Owner	C Conversion deriv	2014-04-22	2014-04-24	45,094	$15.81	$712.9K	0	SEC↗
BOCHNOWSKI JAMES J	10% Owner	C Conversion deriv	2014-04-22	2014-04-24	45,094	—	$0	45,094	SEC↗
BOCHNOWSKI JAMES J	10% Owner	C Conversion deriv	2014-04-22	2014-04-24	424,918	—	$0	0	SEC↗
BOCHNOWSKI JAMES J	10% Owner	C Conversion deriv	2014-04-22	2014-04-24	384,594	—	$0	0	SEC↗
BOCHNOWSKI JAMES J	10% Owner	C Conversion deriv	2014-04-22	2014-04-24	574,933	—	$0	0	SEC↗
BOCHNOWSKI JAMES J	10% Owner	C Conversion deriv	2014-04-22	2014-04-24	347,965	—	$0	0	SEC↗
ROEDER DOUGLAS A	Director, 10% Owner	C Conversion deriv	2014-04-22	2014-04-24	384,594	—	$0	0	SEC↗
ROEDER DOUGLAS A	Director, 10% Owner	C Conversion deriv	2014-04-22	2014-04-24	424,918	—	$0	0	SEC↗
ROEDER DOUGLAS A	Director, 10% Owner	C Conversion deriv	2014-04-22	2014-04-24	970,167	—	$0	0	SEC↗
ROEDER DOUGLAS A	Director, 10% Owner	C Conversion deriv	2014-04-22	2014-04-24	347,965	—	$0	0	SEC↗
ROEDER DOUGLAS A	Director, 10% Owner	C Conversion deriv	2014-04-22	2014-04-24	45,094	$15.81	$712.9K	0	SEC↗
ROEDER DOUGLAS A	Director, 10% Owner	C Conversion deriv	2014-04-22	2014-04-24	45,094	—	$0	45,094	SEC↗
ROEDER DOUGLAS A	Director, 10% Owner	C Conversion deriv	2014-04-22	2014-04-24	574,933	—	$0	0	SEC↗
Thomas Robert	Director	C Conversion deriv	2014-04-22	2014-04-24	6,326	—	$0	6,326	SEC↗
Thomas Robert	Director	C Conversion deriv	2014-04-22	2014-04-24	6,326	$15.81	$100.0K	0	SEC↗
Thomas Robert	Director	C Conversion deriv	2014-04-22	2014-04-24	17,725	—	$0	0	SEC↗
Thomas Robert	Director	C Conversion deriv	2014-04-22	2014-04-24	41,453	—	$0	0	SEC↗
Thomas Robert	Director	C Conversion deriv	2014-04-22	2014-04-24	7,847	—	$0	0	SEC↗
Thomas Robert	Director	C Conversion deriv	2014-04-22	2014-04-24	11,537	—	$0	0	SEC↗
Flynn James E	10% Owner	P Buy	2014-04-22	2014-04-22	94,520	$11.97	$1.13M	324,524	SEC↗
Flynn James E	10% Owner	P Buy	2014-04-22	2014-04-22	75,480	$11.97	$903.5K	261,143	SEC↗
Flynn James E	10% Owner	C Conversion	2014-04-22	2014-04-22	86,834	—	$0	86,834	SEC↗
Flynn James E	10% Owner	C Conversion	2014-04-22	2014-04-22	71,333	—	$0	71,333	SEC↗
Flynn James E	10% Owner	C Conversion	2014-04-22	2014-04-22	221,118	—	$0	221,118	SEC↗
Flynn James E	10% Owner	P Buy	2014-04-22	2014-04-22	118,150	$12.00	$1.42M	204,984	SEC↗
Flynn James E	10% Owner	C Conversion	2014-04-22	2014-04-22	253,384	—	$0	253,384	SEC↗
Flynn James E	10% Owner	P Buy	2014-04-22	2014-04-22	19,980	$12.29	$245.6K	185,663	SEC↗
Flynn James E	10% Owner	P Buy	2014-04-22	2014-04-22	25,020	$12.29	$307.5K	230,004	SEC↗
Flynn James E	10% Owner	P Buy	2014-04-22	2014-04-22	340,425	$12.00	$4.09M	593,809	SEC↗
Flynn James E	10% Owner	P Buy	2014-04-22	2014-04-22	297,075	$12.00	$3.56M	518,193	SEC↗
Flynn James E	10% Owner	P Buy	2014-04-22	2014-04-22	94,350	$12.00	$1.13M	165,683	SEC↗
Scopa James Paul	Director	C Conversion	2014-04-22	2014-04-23	253,066	—	$0	1,776,692	SEC↗
Scopa James Paul	Director	C Conversion	2014-04-22	2014-04-23	379,599	—	$0	1,523,626	SEC↗
Scopa James Paul	Director	C Conversion	2014-04-22	2014-04-23	114,942	—	$0	1,144,027	SEC↗
Scopa James Paul	Director	C Conversion	2014-04-22	2014-04-23	230,756	—	$0	1,029,085	SEC↗
Scopa James Paul	Director	C Conversion	2014-04-22	2014-04-23	798,329	—	$0	798,329	SEC↗
MPM BioVentures IV QP LP	10% Owner	C Conversion	2014-04-22	2014-04-23	114,942	—	$0	1,144,027	SEC↗
MPM BioVentures IV QP LP	10% Owner	C Conversion	2014-04-22	2014-04-23	230,756	—	$0	1,029,085	SEC↗
MPM BioVentures IV QP LP	10% Owner	C Conversion	2014-04-22	2014-04-23	798,329	—	$0	798,329	SEC↗
MPM BioVentures IV QP LP	10% Owner	C Conversion	2014-04-22	2014-04-23	253,066	—	$0	1,776,692	SEC↗
MPM BioVentures IV QP LP	10% Owner	C Conversion	2014-04-22	2014-04-23	379,599	—	$0	1,523,626	SEC↗
KERINS PATRICK J	10% Owner	C Conversion	2014-04-22	2014-04-24	531,758	—	$0	2,295,548	SEC↗
KERINS PATRICK J	10% Owner	C Conversion	2014-04-22	2014-04-24	411,234	—	$0	3,943,269	SEC↗
KERINS PATRICK J	10% Owner	C Conversion	2014-04-22	2014-04-24	797,208	—	$0	1,380,541	SEC↗
KERINS PATRICK J	10% Owner	C Conversion	2014-04-22	2014-04-24	383,249	—	$0	1,763,790	SEC↗
KERINS PATRICK J	10% Owner	C Conversion	2014-04-22	2014-04-24	1,236,487	—	$0	3,532,035	SEC↗
KERINS PATRICK J	10% Owner	P Buy	2014-04-22	2014-04-24	583,333	$12.00	$7.00M	583,333	SEC↗
DRANT RYAN D	Director, 10% Owner	C Conversion	2014-04-22	2014-04-24	383,249	—	$0	1,763,790	SEC↗
DRANT RYAN D	Director, 10% Owner	C Conversion	2014-04-22	2014-04-24	1,236,487	—	$0	3,532,035	SEC↗
DRANT RYAN D	Director, 10% Owner	C Conversion	2014-04-22	2014-04-24	411,234	—	$0	3,943,269	SEC↗
DRANT RYAN D	Director, 10% Owner	P Buy	2014-04-22	2014-04-24	583,333	$12.00	$7.00M	583,333	SEC↗
DRANT RYAN D	Director, 10% Owner	C Conversion	2014-04-22	2014-04-24	797,208	—	$0	1,380,541	SEC↗
DRANT RYAN D	Director, 10% Owner	C Conversion	2014-04-22	2014-04-24	531,758	—	$0	2,295,548	SEC↗
BOCHNOWSKI JAMES J	10% Owner	C Conversion	2014-04-22	2014-04-24	424,918	—	$0	2,217,778	SEC↗
BOCHNOWSKI JAMES J	10% Owner	C Conversion	2014-04-22	2014-04-24	970,167	—	$0	3,187,945	SEC↗
BOCHNOWSKI JAMES J	10% Owner	C Conversion	2014-04-22	2014-04-24	347,965	—	$0	3,535,910	SEC↗
BOCHNOWSKI JAMES J	10% Owner	C Conversion	2014-04-22	2014-04-24	384,594	—	$0	1,792,860	SEC↗
BOCHNOWSKI JAMES J	10% Owner	P Buy	2014-04-22	2014-04-24	833,333	$12.00	$10.00M	833,333	SEC↗
BOCHNOWSKI JAMES J	10% Owner	C Conversion	2014-04-22	2014-04-24	574,933	—	$0	1,408,266	SEC↗
ROEDER DOUGLAS A	Director, 10% Owner	C Conversion	2014-04-22	2014-04-24	424,918	—	$0	2,217,778	SEC↗
ROEDER DOUGLAS A	Director, 10% Owner	P Buy	2014-04-22	2014-04-24	833,333	$12.00	$10.00M	833,333	SEC↗
ROEDER DOUGLAS A	Director, 10% Owner	C Conversion	2014-04-22	2014-04-24	574,933	—	$0	1,408,266	SEC↗
ROEDER DOUGLAS A	Director, 10% Owner	C Conversion	2014-04-22	2014-04-24	384,594	—	$0	1,792,860	SEC↗
ROEDER DOUGLAS A	Director, 10% Owner	C Conversion	2014-04-22	2014-04-24	347,965	—	$0	3,535,910	SEC↗
ROEDER DOUGLAS A	Director, 10% Owner	C Conversion	2014-04-22	2014-04-24	970,167	—	$0	3,187,945	SEC↗
Thomas Robert	Director	C Conversion	2014-04-22	2014-04-24	7,847	—	$0	86,838	SEC↗
Thomas Robert	Director	C Conversion	2014-04-22	2014-04-24	41,453	—	$0	78,991	SEC↗
Thomas Robert	Director	C Conversion	2014-04-22	2014-04-24	17,725	—	$0	37,538	SEC↗
Thomas Robert	Director	C Conversion	2014-04-22	2014-04-24	11,537	—	$0	19,813	SEC↗
CHAVEZ CHRISTOPHER G	President, CEO and Chairman	A Award deriv	2014-04-15	2014-04-17	105,900	—	$0	105,900	SEC↗
Chobotov Michael V.	Chief Technology Officer	A Award deriv	2014-04-15	2014-04-17	70,000	—	$0	70,000	SEC↗
Kramer Michael R	Chief Financial Officer	A Award deriv	2014-04-15	2014-04-17	59,600	—	$0	59,600	SEC↗
Molinari Louis J.	VP Manufacturing Operations	A Award deriv	2014-04-15	2014-04-17	27,050	—	$0	27,050	SEC↗
Whirley Robert G	VP Research and Development	A Award deriv	2014-04-15	2014-04-17	29,800	—	$0	29,800	SEC↗
O'Quinn Shari L	VP Clinical/Regulatory Affai	A Award deriv	2014-04-15	2014-04-17	27,800	—	$0	27,800	SEC↗
Jayaraman Vivek K	VP Global Sales and Marketin	A Award deriv	2014-04-15	2014-04-17	59,600	—	$0	59,600	SEC↗
Elting Kimberley A.	VP, Gen. Counsel and Secreta	A Award deriv	2014-04-15	2014-04-17	35,300	—	$0	35,300	SEC↗
Thomas Robert	Director	A Award deriv	2013-11-29	2014-04-24	4,929	—	$0	4,929	SEC↗
Scopa James Paul	Director	A Award deriv	2013-11-01	2014-04-23	10,266,940	$0.39	$4.00M	10,266,940	SEC↗
DRANT RYAN D	Director, 10% Owner	A Award deriv	2013-11-01	2014-04-24	411,234	—	$0	411,234	SEC↗
BOCHNOWSKI JAMES J	10% Owner	A Award deriv	2013-11-01	2014-04-24	347,965	—	$0	347,965	SEC↗
ROEDER DOUGLAS A	Director, 10% Owner	A Award deriv	2013-11-01	2014-04-24	347,965	—	$0	347,965	SEC↗
Thomas Robert	Director	A Award deriv	2013-11-01	2014-04-24	7,847	—	$0	7,847	SEC↗